Site icon Nairametrics

FY 2018: Fidson Healthcare declares 15 kobo per 50 kobo share

Ohara Pharmaceutical increases take in Fidson, Fidson and Ohara signs partnership, Fidson Healthcare Plc, Fidson list additional shares Fidson and GSK business partnership, Fidson Healthcare Plc records 202% increase in 2020 FY pre-tax profit, Fidson proposes N417 million as dividend for 2020

Fidson Healthcare Plc

Fidson Healthcare Plc has declared a final dividend of 15 kobo per 50 kobo ordinary share for the financial period ended Monday, December 31, 2018.

The dividend will be paid electronically to shareholders whose names appear on the Register of Members as at Wednesday, April 17, 2019, and those who have completed the e-dividend registration and mandated the Payment Date Registrar to pay their dividends directly into their Bank accounts.

The Register of Shareholders will be closed from Thursday, April 18 to Wednesday, April 24, 2019.

Fidson’s Qualification Date has been slated for Wednesday, April 17, 2019.

Understanding Dividend 

A dividend is a payment made by a company to its shareholders, usually as a distribution of profits. When a company earns a profit or surplus, it reinvests a portion of the profit in the business (retained earnings) whilst paying a portion as dividends to the shareholders.

Distribution to shareholders may be in cash (usually a deposit into a bank account) or the issuance of further shares, otherwise known as shares repurchase. But this is usually if the company has a dividend reinvestment plan.

In other words, a dividend is allocated as a fixed amount per share with shareholders receiving a dividend in proportion to their shareholding. For the joint-stock company, paying dividends is not an expense; rather, it is the division of after-tax profits among shareholders.

About Fidson Healthcare Plc

Fidson Healthcare Plc is a leading pharmaceutical manufacturing company in Nigeria. Founded in 1995, the company has relentlessly pursued its goal of becoming a leading player in the pharmaceutical landscape in Nigeria.

Ever since its establishment, Fidson has built and cultured an organisational framework that has helped it gain ascendancy in the industry. The company has crafted the pharmaceutical architecture of the industry over the years of its existence, playing very defining roles in the emergence of the new generation of industry players.

Exit mobile version